<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="with cerebrovascular diseases, and it is currently unclear whether the" exact="infection" post="per se represents an independent stroke risk factor. Regardless"/>
 <result pre="we sought to present the neurological manifestations associated with SARS-CoV-2" exact="infection" post="and COVID-19. Caution is recommended so that clinicians can"/>
 <result pre="septic and cardiogenic shock.10â€&quot;12 However, one case with possible direct" exact="infection" post="of the central nervous system was documented, based on"/>
 <result pre="of the central nervous system was documented, based on SARS-CoV" exact="detection" post="by reverse transcriptaseâ€&quot;polymerase chain reaction (RT-PCR) in the cerebrospinal"/>
 <result pre="(Table 1), but few robust data exist to suggest direct" exact="infection" post="of the nervous system by coronaviruses as yet. Table"/>
 <result pre="that these symptoms should be added to the list of" exact="screening" post="tools for possible COVID-19 infection.29,30 Mild neurological symptoms, such"/>
 <result pre="the most common (52%) symptoms of adult patients with COVID-19" exact="infection" post="were myalgia and fatigue in a recent Chinese study.32"/>
 <result pre="More importantly, all of those patients (n=5) had confirmed SARS-CoV-2" exact="infection" post="but were not critically ill until the stroke occurrence."/>
 <result pre="no genetic material of SARS-CoV-2 was detected during nasopharyngeal swab" exact="testing" post="raising the question of primary seeding of the CNS"/>
 <result pre="question of primary seeding of the CNS versus residual CNS" exact="infection" post="after viral clearance from other sites, a feature observed"/>
 <result pre="Guillainâ€&quot;BarrÃ© syndrome.39 However, the authors acknowledge the fact that SARS-CoV2" exact="infection" post="in their case might as well be a coincidence"/>
 <result pre="in serum or elevated protein and IgG levels. However, RT-PCR" exact="testing" post="for SARS-CoV-2 was negative in all examined CSF samples."/>
 <result pre="present the case report of a patient with confirmed SARS-CoV-2" exact="infection" post="who developed facial nerve palsy during hospitalization (Figure 3)."/>
 <result pre="RT-PCR in the CSF was negative for SARS-CoV-2 and direct" exact="infection" post="of the nervous system could not be established, the"/>
 <result pre="with concomitant COVID-19. A 27-year-old man was admitted to the" exact="isolation" post="ward of a tertiary centre on March 16, 2020,"/>
 <result pre="He received a 1-week course of prednisolone and valacyclovir for" exact="treatment" post="of facial palsy. Upon review 1â€‰week later, his headache"/>
 <result pre="wards, among other general medical wards, have been converted into" exact="quarantine" post="wards for the treatment of infected patients. Routine neurological"/>
 <result pre="medical wards, have been converted into quarantine wards for the" exact="treatment" post="of infected patients. Routine neurological outpatient visits are delayed"/>
 <result pre="patients. Routine neurological outpatient visits are delayed or suspended, and" exact="treatment" post="remains available only for emergency conditions and highly selective"/>
 <result pre="staff, either due to staff redeployment to COVID services, prophylactic" exact="quarantine" post="or direct illness. The remaining healthy personnel are at"/>
 <result pre="from an infectious disease specialist in cases of suspected SARS-CoV-2" exact="infection" post="or from an intensive care unit physician, if the"/>
 <result pre="high fractions of inspired oxygen. Stroke patients with confirmed SARS-CoV-2" exact="infection" post="should be transferred to dedicated COVID-19 wards.54 The need"/>
 <result pre="COVID-19 status, to avoid unnecessary â€˜collateral damageâ€™ through the inadequate" exact="treatment" post="of this often disabling or life-threatening condition (https://eso-stroke.org/news/). Other"/>
 <result pre="Whether those therapies can impair the immune response to SARS-CoV-2" exact="infection" post="is a matter of great concern, but few data"/>
 <result pre="ensure that the patients can present safely for their regular" exact="treatment" post="appointments. Such patients may need to take extra precautions"/>
 <result pre="in the community. Any follow-up visits which are unrelated to" exact="treatment" post="can be postponed or completed through tele-neurology programs. Once"/>
 <result pre="be restarted when symptoms have fully resolved and the repeat" exact="testing" post="is negative. When feasible, prompt treatment re-initiation is particularly"/>
 <result pre="resolved and the repeat testing is negative. When feasible, prompt" exact="treatment" post="re-initiation is particularly important in the cases of fingolimod"/>
 <result pre="In the case of a clinical relapse of COVID-19 patients," exact="treatment" post="with intravenous pulse steroids should be carefully considered and"/>
 <result pre="â€˜trueâ€™ clinical relapse. Respectively, in patients with myasthenia gravis, an" exact="infection" post="can also induce a myasthenic crisis.58 Those patients are"/>
 <result pre="being reduced in number due to the public lockdown and" exact="social distancing" post="measures.70 Drastic times call for drastic measures and the"/>
 <result pre="mechanisms between COVID-19 and stroke, encephalitis or polyneuropathy. However, direct" exact="infection" post="of the neurological system appears to be extremely rare."/>
 <result pre="receiving immunosuppressive therapies may have a higher risk of COVID-19" exact="infection" post="than the one recognized so far. Similarly, patients with"/>
 <result pre="physiotherapists, technicians, as well as personnel from allied departments. The" exact="prevalence" post="of psychological impacts may increase further as the pandemic"/>
 <result pre="are involved in the management of COVID-19 patients hospitalized in" exact="quarantine" post="wards. In conclusion, COVID-19 presents with predominantly mild neurological"/>
 <result pre="case. Neurology2003; 61: 1820â€&quot;1821.14694063 13LauKKYuWCChuCM, et al.Possible central nervous system" exact="infection" post="by SARS coronavirus. Emerg Infect Dis2004; 10: 342â€&quot;344.15030709 14ArbourNDayRNewcombeJ,"/>
 <result pre="al.Neuroinvasion by human respiratory coronaviruses. J Virol2000; 74: 8913â€&quot;8921.10982334 15ArbourNTalbotPJPersistent" exact="infection" post="of neural cell lines by human coronaviruses. Adv Exp"/>
 <result pre="J Infect Dis2014; 29: 301â€&quot;306.25303830 19KimJEHeoJHKimHO, et al.Neurological complications during" exact="treatment" post="of middle east respiratory syndrome. J Clin Neurol2017; 13:"/>
 <result pre="ahead of print 3132020 DOI: 10.1161/STROKEAHA.120.029701. 47FedericoABrain awareness week, CoVID-19" exact="infection" post="and neurological sciences. Neurol Sci2020; 41: 747â€&quot;748.32180157 48LowZXYeoKASharmaVK, et"/>
</results>
